Business · 25/10/2017
FDA Announces Draft Guidances for Drug-Drug Interaction Studies
The FDA has released two draft guidances to help pharmaceutical companies plan and evaluate potential drug-drug interactions during the development process, replacing a 2012 draft guidance.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →